Bausch Health Companies | Bruttoergebnis Vom Umsatz



Gross Profit On Sales Veränderung Datum
Amgen USD 5.54B 430M 2025-03
ANI Pharmaceuticals USD 124.08M 13.79M 2025-03
Aurora Cannabis CAD 9.35M 6.18M 2024-12
Bausch Health Companies USD 1.77B 208M 2025-06
Biogen USD 2.04B 238.8M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Canopy Growth CAD 24.1M 2.26M 2024-12
Corcept Therapeutics USD 191M 36.19M 2025-06
Danaher USD 3.52B 3M 2025-06
Drreddys Laboratories INR 49.05B 1.28B 2024-12
Eli Lilly USD 10.5B 624.7M 2025-03
Gilead Sciences USD 5.58B 453M 2025-06
Novo Nordisk 64.01B 1.19B 2025-06
Pacira USD 125.91M 8.71M 2025-06
Perrigo USD 362.9M 29.4M 2025-06
Prestige Brands USD 140.33M 29.68M 2025-06
Supernus Pharmaceuticals USD 127.81M 6.25M 2025-06
Vertex Pharmaceuticals USD 2.56B 150M 2025-06
Zoetis USD 1.78B 180M 2025-06


Bausch Health Companies Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.